EQR
54
-2
FMC
31
5
DG
2
-6
CINF
47
2
HSY
34
3
COP
56
2
FRT
39
-2
BA
52
2
VRTX
46
2
HSIC
54
-3
CL
56
5
HRL
39
15
JPM
63
-4
DNB
78
6
SO
55
-2
XEL
67
2
SIG
43
3
MKC
56
8
PVH
52
-3
PDCO
35
-3
EQR
54
-2
FMC
31
5
DG
2
-6
CINF
47
2
HSY
34
3
COP
56
2
FRT
39
-2
BA
52
2
VRTX
46
2
HSIC
54
-3
CL
56
5
HRL
39
15
JPM
63
-4
DNB
78
6
SO
55
-2
XEL
67
2
SIG
43
3
MKC
56
8
PVH
52
-3
PDCO
35
-3
Financhill
Back

Applied Therapeutics Quote, Financials, Valuation and Earnings

America's enemies are regrouping & it may sucker punch your savings

Click here to learn more.
Buy
72

APLT
Applied Therapeutics

Last Price:
9.23
Seasonality Move:
58.48%

7 Day Trial

ALL ACCESS PASS

$ 7

Trump's IRS Hands Massive 'Victory Gift' To 401K Owners

Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.

Applied Therapeutics Price Quote

$9.23
-0.20 (-2.12%)
(Updated: November 21, 2024 at 10:35 AM ET)

Applied Therapeutics Key Stats

Buy
72
Applied Therapeutics (APLT) is a Buy
Day range:
$8.82 - $9.86
52-week range:
$1.79 - $10.62
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
170.82%
Volume:
1.4M
Avg. volume:
1.7M
1-year change:
373.87%
Market cap:
$1B
Revenue:
$10M
EPS:
$-1.61

How Much Does Applied Therapeutics Make?

Is Applied Therapeutics Growing As A Company?

Data Unavailable

Applied Therapeutics Stock Price Performance

What Is Applied Therapeutics 52-Week High & Low?

Applied Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Applied Therapeutics?

Is Applied Therapeutics Cash Flow Positive?

  • What Is APLT Cash Flow From Operations?
    Cash flow from operations (TTM) is -$81.8M
  • What Is Applied Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $143.3M
  • What Is Applied Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $0

Applied Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    APLT return on invested capital is -790.52%
  • What Is Applied Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -192.86%
  • What Is APLT Return On Equity?
    ROE is a measure of profitability and is -797.82%

Applied Therapeutics Earnings Date & Stock Price

Applied Therapeutics Competitors

Applied Therapeutics Dividend Yield

Applied Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -195.49%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 5
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 14.67
Upside from Last Price: 55.53%

Major Shareholders

  • How many APLT shares are owned by institutional investors?
    162.8M APLT shares are owned by institutional investors
  • How many APLT shares are owned by insiders?
    8.3M APLT shares are owned by insiders